Genetics of anaplastic large cell lymphoma

References

• Delsol G, Falini B, Muller-Hermelink HK, et al. Anaplastic large cell lymphoma, ALK-positive. In: Swerdlow S, Campo E, Harris N, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th ed. World Health Organization Classification of Tumours. Lyon: International Agency for Research on Cancer; 2008. pp. 312–316.
   Google Scholar
• Mason DY, Harris NL, Delsol G, et al. Anaplastic large cell lymphoma, ALK-negative. In: Swerdlow S, Campo E, Harris N, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. World Health Organization Classification of Tumours. Lyon: International Agency for Research on Cancer; 2008. pp. 317–319.
   Google Scholar
• Ralfkiaer E, Willemze R, Paulli M, et al. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Swerdlow S, Campo E, Harris N, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4 ed. World Health Organization Classification of Tumours. Lyon: International Agency for Research on Cancer; 2008. pp. 300–301.
   Google Scholar
• Barreca A, Lasorsa E, Riera L, et al. Anaplastic lymphoma kinase in human cancer. J Mol Endocrinol 2011;47:R11–23.
   PubMed Web of Science ®Google Scholar
• Rowley JD. Chromosomal translocations: revisited yet again. Blood 2008;112:2183–2189.
   PubMed Web of Science ®Google Scholar
• Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994;263:1281–1284.
   PubMed Web of Science ®Google Scholar
• Pulford K, Lamant L, Espinos E, et al. The emerging normal and disease-related roles of anaplastic lymphoma kinase. Cell Mol Life Sci 2004;61:2939–2953.
   PubMed Web of Science ®Google Scholar
• Damm-Welk C, Klapper W, Oschlies I, et al. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation. Br J Haematol 2009;146:306–309.
   PubMed Web of Science ®Google Scholar
• Feldman AL, Vasmatzis G, Asmann YW, et al. Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma. Genes Chromosomes Cancer 2013;52:1097–1102.
   PubMed Web of Science ®Google Scholar
• Liang X, Branchford B, Greffe B, et al. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. J Pediatr Hematol Oncol 2013;35:e209–213.
   PubMedGoogle Scholar
• Monaco S, Tsao L, Murty VV, et al. Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase. Am J Hematol 2007;82:59–64.
   PubMed Web of Science ®Google Scholar
• Moritake H, Shimonodan H, Marutsuka K, et al. C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: identification of a novel fusion gene ALO17/C-MYC. Am J Hematol 2011;86:75–78.
   PubMed Web of Science ®Google Scholar
• Oschlies I, Lisfeld J, Lamant L, et al. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study. Haematologica 2013;98:50–56.
   PubMed Web of Science ®Google Scholar
• Pulitzer M, Ogunrinade O, Lin O, Steinhertz P. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient. J Cutan Pathol 2015;42:182–187.
   PubMed Web of Science ®Google Scholar
• Kadin ME, Pinkus JL, Pinkus GS, et al. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative. Am J Surg Pathol 2008;32:1421–1426.
   PubMed Web of Science ®Google Scholar
• Zamo A, Chiarle R, Piva R, et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 2002;21:1038–1047.
   PubMed Web of Science ®Google Scholar
• Slupianek A, Nieborowska-Skorska M, Hoser G, et al. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis. Cancer Res 2001;61:2194–2199.
   PubMed Web of Science ®Google Scholar
• Bai RY, Dieter P, Peschel C, et al. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol 1998;18:6951–6961.
   PubMed Web of Science ®Google Scholar
• Amin HM, Lai R. Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood 2007;110:2259–2267.
   PubMed Web of Science ®Google Scholar
• McDonnell SR, Hwang SR, Basrur V, et al. NPM-ALK signals through glycogen synthase kinase 3beta to promote oncogenesis. Oncogene 2012;31:3733–3740.
   PubMed Web of Science ®Google Scholar
• Anastasov N, Bonzheim I, Rudelius M, et al.C/EBPbeta expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica 2010;95:760–767.
   PubMed Web of Science ®Google Scholar
• Bonzheim I, Irmler M, Klier-Richter M, et al. Identification of C/EBPbeta target genes in ALK+ anaplastic large cell lymphoma (ALCL) by gene expression profiling and chromatin immunoprecipitation. PLoS ONE 2013;8:e64544.
   PubMedGoogle Scholar
• Zhang Q, Wang H, Kantekure K, et al. Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS. Blood 2011;118:3062–3071.
   PubMed Web of Science ®Google Scholar
• Feldman AL, Dogan A, Smith DI, et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively-parallel genomic sequencing. Blood 2011;117:915–919.
   PubMed Web of Science ®Google Scholar
• Alonso A, Merlo JJ, Na S, et al. Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR). J Biol Chem 2002;277: 5524–5528.
   PubMed Web of Science ®Google Scholar
• Han YC, Park CY, Bhagat G, et al. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med;207:475–489.
   PubMed Web of Science ®Google Scholar
• Gebeshuber CA, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 2009;10:400–405.
   PubMed Web of Science ®Google Scholar
• Vasmatzis G, Johnson SH, Knudson RA, et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 2012;120:2280–2289.
   PubMed Web of Science ®Google Scholar
• Parrilla Castellar ER, Jaffe ES, Said JW, et al. ALK- negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 2014;124: 1473–1480.
   PubMed Web of Science ®Google Scholar
• Ralfkiaer E, Cerroni L, Sander CA, et al. Mycosis fungoides. In: Swerdlow S, Campo E, Harris N, et al. , editors. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th ed. World Health Organization Classification of Tumours. Lyon: International Agency for Research on Cancer; 2008. pp. 296–298.
   Google Scholar
• Feldman AL, Law M, Remstein ED, et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 2009;23:574–580.
   PubMed Web of Science ®Google Scholar
• Wada DA, Law ME, Hsi ED, et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol 2011;24:596–605.
   PubMed Web of Science ®Google Scholar
• Pham-Ledard A, Prochazkova-Carlotti M, Laharanne E, et al. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases. J Invest Dermatol 2010;130:816–825.
   PubMed Web of Science ®Google Scholar
• Kiran T, Demirkesen C, Eker C, et al. The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: a study of 53 cases. Leuk Res 2013;37:396–400.
   PubMed Web of Science ®Google Scholar
• Karai LJ, Kadin ME, Hsi ED, et al. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis. Am J Surg Pathol 2013;37:1173–1181.
   PubMed Web of Science ®Google Scholar
• Laharanne E, Oumouhou N, Bonnet F, et al. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol 2010;130:1707–1718.
   PubMed Web of Science ®Google Scholar
• Chavan RN, Bridges AG, Knudson RA, et al. Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course. Blood Cancer J 2014;4:e253.
   PubMedGoogle Scholar
• Sciallis AP, Law ME, Inwards DJ, et al. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol 2012;25:983–992.
   PubMed Web of Science ®Google Scholar
• Wang W, Cai Y, Sheng W, Lu H, Li X. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:96–104.
   PubMed Web of Science ®Google Scholar
• Roden AC, Macon WR, Keeney GL, et al. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 2008; 21:455–463.
   PubMed Web of Science ®Google Scholar
• Miranda RN, Aladily TN, Prince HM, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol 2014;32:114–120.
   PubMed Web of Science ®Google Scholar
• Salaverria I, Bea S, Lopez-Guillermo A, et al. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol 2008; 140:516–526.
   PubMed Web of Science ®Google Scholar
• Zettl A, Rudiger T, Konrad MA, et al. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004;164:1837–1848.
   PubMed Web of Science ®Google Scholar
• Boi M, Rinaldi A, Kwee I, et al. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood 2013;122: 2683–2693.
   PubMed Web of Science ®Google Scholar
• van Kester MS, Tensen CP, Vermeer MH, et al. Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators. J Invest Dermatol 2010;130:563–575.
   PubMed Web of Science ®Google Scholar
• Thompson MA, Stumph J, Henrickson SE, et al. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol 2005;36:494–504.
   PubMed Web of Science ®Google Scholar
• Lamant L, de Reynies A, Duplantier MM, et al. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood 2007;109:2156–2164.
   PubMed Web of Science ®Google Scholar
• Piva R, Agnelli L, Pellegrino E, et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 2010;28:1583–1590.
   PubMed Web of Science ®Google Scholar
• Agnelli L, Mereu E, Pellegrino E, et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood 2012;120: 1274–1281.
   PubMed Web of Science ®Google Scholar
• Eckerle S, Brune V, Doring C, et al. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. Leukemia 2009;23:2129–2138.
   PubMed Web of Science ®Google Scholar
• Xing X, Flotte TJ, Law ME, et al. Expression of the chemokine receptor gene, CCR8, is associated with DUSP22 rearrangements in anaplastic large cell lymphoma. Appl Immunohistochem Mol Morphol 2014 Nov 11. [Epub ahead of print].
   PubMedGoogle Scholar
• Valencia-Sanchez MA, Liu J, Hannon GJ, et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20:515–524.
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102–114.
   PubMed Web of Science ®Google Scholar
• Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nature reviews. Genetics 2009;10:704–714.
   PubMed Web of Science ®Google Scholar
• Merkel O, Hamacher F, Laimer D, et al. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma. Proc Natl Acad Sci U S A 2010;107:16228–16233.
   PubMed Web of Science ®Google Scholar
• Brock M, Trenkmann M, Gay RE, et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 2009;104:1184–1191.
   PubMed Web of Science ®Google Scholar
• Spaccarotella E, Pellegrino E, Ferracin M, et al. STAT3-mediated activation of microRNA cluster 17∼92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica 2014;99:116–124.
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435:828–833.
   PubMed Web of Science ®Google Scholar
• Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008;133:217–222.
   PubMed Web of Science ®Google Scholar
• Liu C, Iqbal J, Teruya-Feldstein J, et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 2013;122:2083–2092.
   PubMed Web of Science ®Google Scholar
• Mehrotra M, Medeiros LJ, Luthra R, et al. Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma. Hum Pathol 2014;45:1995–2005.
   PubMed Web of Science ®Google Scholar
• Matsuyama H, Suzuki HI, Nishimori H, et al. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 2011; 118:6881–6892.
   PubMed Web of Science ®Google Scholar
• Benner MF, Ballabio E, van Kester MS, et al. Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides. Exp Dermatol 2012;21:632–634.
   PubMed Web of Science ®Google Scholar